Invest Northwest Life Sciences CEO & Investor Forum, 4/26 – 27, 2005, Seattle, WA

2005-04-26 08:00:00

Bell Harbor Conference Center in downtown Seattle.

Contact: Pam Love, 206-624-1967 [email protected]

Invest Northwest© to feature innovative Pacific Northwest biotechnology and medical device firms

Invest Northwest Life Sciences CEO & Investor
Forum Slated for April 26 – 27, 2005

The Washington Biotechnology & Biomedical Association (WBBA) in collaboration with BC Biotech, BioAlberta and the Oregon Biosciences Association will host its fourth annual CEO and investor conference, Invest NorthwestTM, April 26 and 27 2005 at Bell Harbor Conference Center in downtown Seattle.

Invest NorthwestTM is a two-day forum for institutional investors, analysts, investment bankers, fund managers, venture capitalists, angel investors and pharmaceutical and biotech corporate partners to meet with CEOs and senior executives from public and private life sciences companies based in Washington, Oregon, Idaho, Montana, British Columbia and Alberta.

The Pacific Northwest is home to nearly 300 companies involved in the development and commercialization of new therapeutics, diagnostics, vaccines, medical devices, bioinformatics, genomics, proteomics and other drug discovery platforms.

The forum will feature 58 company presentations that will highlight the innovative life science research and product development that has established the Pacific Northwest as a leading bioscience region. The event provides networking opportunities for industry leaders.

Attendance is expected to exceed 500. Presentation and application information will be available on http://www.investnorthwest.org in November.

About the WBBA

Based in Seattle, the Washington Biotechnology & Biomedical Association (WBBA) is a not-for-profit association of Washington state-based biotechnology and medical device companies, research institutions and related organizations. For more information about WBBA, visit http://www.wabio.com.